Goldman Sachs’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
AAP
FIB
RA
Goldman Sachs's REVS Position: Q2 2026 in Review
Goldman Sachs sold out of Columbia Research Enhanced Value ETF (REVS) in Q2 2026, closing a stake of 22,256 shares — an estimated $637K sold.
Goldman Sachs first reported a position in REVS in Q1 2026 and held it in 1 quarter. The position peaked at $637K in Q1 2026. 38 funds tracked by Wall St. Rank hold REVS as of Q2 2026.
- Goldman Sachs reported no remaining Columbia Research Enhanced Value ETF position as of Q2 2026 after selling out during the quarter.
- Goldman Sachs sold 22,256 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $637K.
- Goldman Sachs first reported a position in Columbia Research Enhanced Value ETF in Q1 2026 and held it in 1 quarter.
- Goldman Sachs's Columbia Research Enhanced Value ETF position peaked at $637K in Q1 2026.
- 38 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.